CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigate Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
13,421 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0934

GW-501516 (Cardarine) Raw

Filed under Raw Materials. The bureau holds 41 laboratory returns for this compound from 12 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

12 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760A610.09.910.023 May 202623 May 2026
Tianjin Finder Chemical TFCCASE #VI-2026-0693A89.99.910.014 Nov 202516 Apr 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538A49.57.910.024 May 202624 May 2026
Hunan Ruiwang Technology CenterCASE #VI-2026-0027X19.59.59.53 Jul 20253 Jul 2025
Shanghai Sigma Audley SSACASE #VI-2026-0486A69.07.510.023 May 202623 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284A78.56.910.024 May 202624 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704A28.58.58.524 May 202624 May 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594A58.06.49.021 May 202621 May 2026
Peptide CraftersCASE #VI-2026-0994X15.65.65.66 May 20256 May 2025
ZZQ PeptidesCASE #VI-2026-0550X15.15.15.124 Apr 202524 Apr 2025
Chimera PeptidesCASE #VI-2026-0260X13.43.43.47 May 20257 May 2025
NuLife PeptidesCASE #VI-2026-0980X10.70.70.76 May 20256 May 2025

Open any subject to view the batch-level evidence for GW-501516 (Cardarine) Raw alone.